iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes
1 other identifier
interventional
195
1 country
4
Brief Summary
This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress, and health insurance literacy outcomes. The investigators are doing this study because it will help to better understand how to support health insurance and financial stress and improve self-management outcomes in young adults with type 1 diabetes. The investigators want to understand how the iHERO Toolkit helps all young adults with diabetes, but especially those on Medicaid and who are racially or ethnically diverse. The investigators will ask participants to participate at four-time points over one year. For the first time, participants will fill out online enrollment and demographic forms and 9 surveys. The 9 surveys have 8-40 short questions each, estimated to take about 45 minutes. Participants will also be asked to complete a home A1c collection with a University Hospitals team member on Zoom.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2024
CompletedFirst Posted
Study publicly available on registry
April 4, 2024
CompletedStudy Start
First participant enrolled
May 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 22, 2026
January 16, 2026
January 1, 2026
2.5 years
March 29, 2024
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in financial stress as measured by the Personal Financial Well-Being Scale© (PFW) Scale (PFW)
The PFW is an 8-item scale used to measure financial stress with a Likert scale of 1-10 with 1 being no financial stress and 10 being an overwhelming level of financial stress. Lower scores (≤ 4.4) indicate high financial stress, while scores ranging from 4.5-6.4 indicate average stress, and scores ≥ 6.5 indicate low stress.
Baseline, 1 month, 6 months, 12 months
Change in health insurance literacy as measured by The Health Insurance Literacy Measure (HILM) Measure (HILM)
The HILM is a 21-item measure used to rate confidence in selecting and using health insurance with 0 representing little confidence and 4 representing highest confidence. The scores of the items are summed and range from 0 to 84, with higher scores representing greater levels of health insurance literacy.
Baseline, 1 month, 6 months, 12 months
Change in diabetes-specific quality of life as measured by The Type 1 Diabetes and Life Young Adult (T1DAL- Young Adult) for ages 18-25 or The Type 1 Diabetes and Life (T1DAL- Adult) for Ages 26-30.
T1DAL-Young Adult and T1DAL- Adult are scored on a scale of 0-100 with higher scores indicating better health related quality of life.
Baseline, 1 month, 6 months, 12 months
Change in transition navigation readiness as measured by the The Readiness for Emerging Adults with Diabetes Diagnosed in Youth (READDY) Navigation Subscale
READDY navigation sub-scale scores of 1-3 indicate lower levels of confidence and scores of 4-5 indicate higher levels of confidence in healthcare navigation.
Baseline, 1 month, 6 months, 12 months
Change in HbA1c levels as measured by self-collect capillary HbA1c
Baseline, 6 months, 12 months
Study Arms (2)
iHERO Resource Group
EXPERIMENTALToolkit consisting of micro-videos and supplemental online resources.
Control
NO INTERVENTIONInterventions
iHERO Toolkit consists of micro-videos and supplemental online resources. Participants will have access to the toolkit housed on pathfactory for 30 days.
Eligibility Criteria
You may qualify if:
- Age range: 18-30 years
- Diagnosis of type 1 diabetes (T1D)
- T1D duration for one year or longer
- Geographical location: residing in the United States.
You may not qualify if:
- Inability to answer questions due to cognitive status.
- Inability to read or understand English.
- Diagnosis of insulin-dependent diabetes that is not T1D such as cystic fibrosis-related diabetes, maturity-onset diabetes of the young, or insulin-dependent type 2 diabetes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
University of Florida Diabetes Institute
Gainesville, Florida, 32610, United States
University Hospitals
Cleveland, Ohio, 44106, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Related Publications (2)
Blanchette JE, Toly VB, Wood JR. Financial stress in emerging adults with type 1 diabetes in the United States. Pediatr Diabetes. 2021 Aug;22(5):807-815. doi: 10.1111/pedi.13216. Epub 2021 May 18.
PMID: 33887095BACKGROUNDBlanchette JE, Allen NA, Litchman ML. The Feasibility and Acceptability of a Community-Developed Health Insurance and Financial Toolkit for Emerging Adults With Type 1 Diabetes. Sci Diabetes Self Manag Care. 2022 Jun;48(3):174-183. doi: 10.1177/26350106221087474. Epub 2022 Mar 15.
PMID: 35287511BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julia Blanchette, PhD
University Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine, Nurse Scientist
Study Record Dates
First Submitted
March 29, 2024
First Posted
April 4, 2024
Study Start
May 14, 2024
Primary Completion (Estimated)
November 22, 2026
Study Completion (Estimated)
November 22, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share